Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Interpace Diagnostics Group Inc (NASDAQ:IDXG)

0.182
Delayed Data
As of Sep 23
 +0.0035 / +1.96%
Today’s Change
0.16
Today|||52-Week Range
2.04
-60.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues126.9M150.8M119.9M9.4M
 
 
 
 
 
Cost of Goods Sold114.4M142.4M114.6M5.7M
 
 
 
 
 
Depreciation And Amortization2.0M1.4M2.4M5.0M
 
 
 
 
 
 
Operating ExpensesGross Income10.4M7.0M3.0M-1.3M
 
 
 
 
 
General Expenses11.5M11.3M14.3M27.7M
 
 
 
 
 
Research And Development------2.3M
 
 
Total Operating Expenses127.9M155.1M131.3M38.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.0M-4.3M-11.4M-29.0M
 
 
 
 
 
Extraordinary Credit0.000.00--8.0M
 
 
Extraordinary Charge-24.2M0.00-2.1M-19.4M
 
 
 
 
Interest Expense On Debt0.000.00602.0K3.7M
 
 
 
Other Expenses-28.0K-59.0K-68.0K-93.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.3M-4.3M-14.1M-44.2M
 
 
 
 
 
Income Taxes-208.0K-180.0K-4.7M-13.1M
 
 
 
 
 
Discontinued Operations-59.0K-49.0K-6.7M-1.9M
 
 
 
 
 
Extraordinary Items0.000.000.0021.6M
 
 
Net Income-25.5M-4.6M-16.1M-33.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS14.6M14.7M14.9M15.5M
 
 
 
 
 
Shares To Calculate EPS Diluted14.6M14.7M14.9M15.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.75-$0.31-$1.08-$0.73
 
 
 
 
 
EPS Diluted-$1.75-$0.31-$1.08-$2.13